Loading clinical trials...
Loading clinical trials...
Emicizumab for Severe VON Willebrand Disease (VWD) and VWD/Hemophilia A
Conditions
Interventions
Emicizumab
Locations
12
United States
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD)
Orange, California, United States
Stanford University: Stanford Children's Health
Redwood City, California, United States
University of Miami - Miller School of Medicine
Coral Gables, Florida, United States
St. Joseph's Children's Hospital - Center for Bleeding and Clotting Disorders
Tampa, Florida, United States
Bleeding and Clotting Disorders Institute (BCDI)
Peoria, Illinois, United States
Innovative Hematology, Inc. (IHI)
Indianapolis, Indiana, United States
Start Date
November 1, 2022
Primary Completion Date
June 1, 2027
Completion Date
February 1, 2028
Last Updated
April 3, 2026
Lead Sponsor
Bleeding and Clotting Disorders Institute Peoria, Illinois
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions